You Position: Home > Paper

Pay attention to the potential risks of anti-vascular endothelial growth factor therapy for neovascular disease

( views:519, downloads:414 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
Issue:
1
DOI:
10.3760/cma.j.issn.1005-1015.2010.01.01
Key Word:
脉络膜新生血管化/药物疗法;视网膜新生血管化/药物疗法;抗体,单克隆/治疗应用;抗体,单克隆/副作用;血管内皮生长因子类;Choroidal neovascularization/drug therapy;Retinal neovascularization/drug therapy;Antibodies,monoclonal/therapeutic use;Antibodies,monoclonal/adverse effects;Vascular endothelial growth factors

Abstract: Anti-vascular dndothelial growth factor (VEGF) drugs have open up a new treatment channel for ocular neovascular diseases.A lots of clinical data has proved that anti VEGF drugs are effective and safe.But we should also notice that long-term and excessive usage of anti-VEGF drugs brings some new problems and complications,and even affect the normal ocular physiological process of the angiogenesis and retinal blood flow.So,it is necessary to pay attention to the problems and potential risks of excessive usage of anti VEGF therapies for ocular neovascular disease.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn